Kura Oncology is a biopharmaceutical company focused on the development of innovative medicines for the treatment of cancer. The company is committed to advancing its proprietary drug candidates that target specific genetic and epigenetic drivers of cancer progression, utilizing their expertise in precision medicine to address unmet medical needs. Through rigorous research and clinical trials, Kura aims to bring transformative therapies to patients suffering from various types of cancer, including rare and hard-to-treat forms. Their goal is to improve outcomes and quality of life for patients by providing targeted treatments that leverage the unique characteristics of their tumors. Read More
Boston, MA – October 3, 2025 – Leap Therapeutics, Inc. (NASDAQ: LPTX) experienced a sharp downturn in its stock performance today, with shares falling by over 20% in intraday trading. This significant decline marks a notable correction for the biotechnology company, which had seen its stock surge dramatically in the preceding days,
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
